Abstract
Serum (1 → 3)-β-D-glucan levels and clinical findings were evaluated in 229 inpatients with connective tissue diseases (CTDs) during the period between June and October 2004. The mean serum (1 → 3)-β-D-glucan level was 129.7 ± 207.6 pg/mL in patients with a definitive diagnosis of fungal infections and 10.5 ± 8.6 pg/mL in patients without fungal infections. Analysis of the diagnostic sensitivity/specificity for various (1 → 3)-β-D-glucan cutoff levels gave the best results for a cutoff level of 15 pg/mL, with a sensitivity of 92.3% and specificity of 81.3%. This level was therefore determined to be the optimal cutoff in patients with CTDs.
| Original language | English |
|---|---|
| Pages (from-to) | 366-369 |
| Number of pages | 4 |
| Journal | Modern Rheumatology |
| Volume | 20 |
| Issue number | 4 |
| DOIs | |
| Publication status | Published - 08-01-2010 |
| Externally published | Yes |
All Science Journal Classification (ASJC) codes
- Rheumatology
Fingerprint
Dive into the research topics of 'Evaluation of the clinical cutoff level of serum (1 → 3)-β-d-glucan in patients with connective tissue diseases complicated by deep fungal infections'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver